top of page
For US Healthcare Professionals
Quick Search
Find accurate, up-to-date medical information about Letybo®.
Simply enter keywords and the tool will return the most relevant resources, FAQs, and supporting documents in seconds—streamlining access to the information you need.
Not Found - If you are unable to find the document you’re looking for, please submit a medical inquiry.
Letybo® for Platysma Bands: Evidence-based Treatment and Dosing
Effective Date: 08/2025
Disclaimer: These documents are provided for your personal use only. Any redistribution, reproduction, modification, or electronic sharing of the content, in whole or in part, is strictly prohibited without prior consent. You may print documents received electronically solely for your personal reference. For further information, please contact us directly.
Letybo® for Frontalis (Forehead): Evidence-based Treatment and Dosing
Effective Date: 08/2025
Disclaimer: These documents are provided for your personal use only. Any redistribution, reproduction, modification, or electronic sharing of the content, in whole or in part, is strictly prohibited without prior consent. You may print documents received electronically solely for your personal reference. For further information, please contact us directly.
Letybo® for Orbicularis Oculi (Crow’s Feet): Evidence-based Treatment and Dosing
Effective Date: 08/2025
Disclaimer: These documents are provided for your personal use only. Any redistribution, reproduction, modification, or electronic sharing of the content, in whole or in part, is strictly prohibited without prior consent. You may print documents received electronically solely for your personal reference. For further information, please contact us directly.
Letybo®: Amount of Neurotoxin Protein
Effective Date: 08/2025
Disclaimer: These documents are provided for your personal use only. Any redistribution, reproduction, modification, or electronic sharing of the content, in whole or in part, is strictly prohibited without prior consent. You may print documents received electronically solely for your personal reference. For further information, please contact us directly.
Letybo®: Field of Effect and Diffusion Characteristics
Effective Date: 08/2025
Disclaimer: These documents are provided for your personal use only. Any redistribution, reproduction, modification, or electronic sharing of the content, in whole or in part, is strictly prohibited without prior consent. You may print documents received electronically solely for your personal reference. For further information, please contact us directly.
Diffusion Characteristics of LetibotulinumtoxinA, OnabotulinumtoxinA, and AbobotulinumtoxinA and its Impact on Muscle Relaxation: A Randomized Split-Face Clinical Trial (Free)
Maxine Bennek, Daniela Rudowitz, Martina Kerscher
Dermatol Ther (Heidelb). 2025 Jun 17. doi: 10.1007/s13555-025-01458-3
Consensus Recommendations for Treatment of the Upper Face With LetibotulinumtoxinA
Ho-Sung Choi, Jimmy Wang, Dahlia Tauber, Aemillia Brown, Kathleen Chang, Steven Liew, Kyo-Ho Yi
Plast Aesthet Nurs (Phila). 2024 Oct-Dec;44(4):239-250. doi: 10.1097/PSN.0000000000000585. Epub 2024 Sep 27.
LetibotulinumtoxinA Attenuates the Psychological Burden of Glabellar Lines and Is Associated With High Subject Satisfaction in Phase 3 Clinical Trials
Sue Ellen Cox, Joely Kaufman-Janette, Joel L Cohen , Michael Gold , John Joseph, Mark S Nestor, Berthold Rzany , Susan Taylor , Jihao Zhou, Michael Cecerle, Elena Pueraro, Ryan Irvine, Steven Dayan
Dermatol Surg. 2024 Jun 1;50(6):535-541. doi: 10.1097/DSS.0000000000004152. Epub 2024 Mar 12.
Documents obtained from search may contain information that is not included in the approved Prescribing Information. BENEV does not endorse the use of its products in a manner not consistent with the approved label. Please refer to the full Prescribing Information for complete information and safety details.
bottom of page